全文获取类型
收费全文 | 1302747篇 |
免费 | 95561篇 |
国内免费 | 3942篇 |
专业分类
耳鼻咽喉 | 18353篇 |
儿科学 | 42560篇 |
妇产科学 | 38047篇 |
基础医学 | 189842篇 |
口腔科学 | 35990篇 |
临床医学 | 111797篇 |
内科学 | 254876篇 |
皮肤病学 | 26789篇 |
神经病学 | 100431篇 |
特种医学 | 50886篇 |
外国民族医学 | 388篇 |
外科学 | 200107篇 |
综合类 | 31267篇 |
现状与发展 | 6篇 |
一般理论 | 303篇 |
预防医学 | 94726篇 |
眼科学 | 29696篇 |
药学 | 100644篇 |
47篇 | |
中国医学 | 4661篇 |
肿瘤学 | 70834篇 |
出版年
2018年 | 12903篇 |
2016年 | 11044篇 |
2015年 | 13054篇 |
2014年 | 17621篇 |
2013年 | 25890篇 |
2012年 | 35489篇 |
2011年 | 38105篇 |
2010年 | 22642篇 |
2009年 | 21250篇 |
2008年 | 36342篇 |
2007年 | 39189篇 |
2006年 | 39682篇 |
2005年 | 38911篇 |
2004年 | 37069篇 |
2003年 | 36034篇 |
2002年 | 35464篇 |
2001年 | 58477篇 |
2000年 | 59981篇 |
1999年 | 51105篇 |
1998年 | 14484篇 |
1997年 | 13073篇 |
1996年 | 13232篇 |
1995年 | 12520篇 |
1994年 | 11901篇 |
1993年 | 10948篇 |
1992年 | 41085篇 |
1991年 | 40438篇 |
1990年 | 39972篇 |
1989年 | 38770篇 |
1988年 | 36190篇 |
1987年 | 35395篇 |
1986年 | 33760篇 |
1985年 | 32164篇 |
1984年 | 23934篇 |
1983年 | 20832篇 |
1982年 | 12380篇 |
1981年 | 10939篇 |
1979年 | 22652篇 |
1978年 | 15878篇 |
1977年 | 13738篇 |
1976年 | 12974篇 |
1975年 | 14210篇 |
1974年 | 16691篇 |
1973年 | 16088篇 |
1972年 | 15321篇 |
1971年 | 14236篇 |
1970年 | 13219篇 |
1969年 | 12741篇 |
1968年 | 11985篇 |
1967年 | 10483篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
C. M. de Bont N. Eerden W. C. Boelens G. J. M. Pruijn 《Clinical and experimental immunology》2020,199(1):1-8
Neutrophils can form neutrophil extracellular traps (NETs) to capture microbes and facilitate their clearance. NETs consist of decondensed chromatin decorated with anti-microbial proteins. Here, we describe the effect of neutrophil proteases on the protein content of NETs. We show that the neutrophil serine proteases degrade several neutrophil proteins associated with NETs. Interestingly, the anti-bacterial proteins associated with NETs, such as myeloperoxidase, calgranulin B and neutrophil elastase (NE), seem to be less susceptible to proteolytic degradation than other NET proteins, such as actin and MNDA. NETs have been proposed to play a role in autoimmune reactions. Our data demonstrate that a large number of the autoepitopes of NET proteins that are recognized by autoantibodies produced by systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients are also removed by the proteases. In conclusion, neutrophil serine proteases have a major impact on the NET proteome and the proteolytic changes of NET-associated proteins may counteract autoimmune reactions to NET components. 相似文献
63.
Nicola Flaum Emma J. Crosbie Richard J. Edmondson Miriam J. Smith Dafydd G. Evans 《Clinical genetics》2020,97(1):54-63
Ovarian cancer is the fourth most common cause of cancer-related death in women in the developed world, and one of the most heritable cancers. One of the most significant risk factors for epithelial ovarian cancer (EOC) is a family history of breast and/or ovarian cancer. Combined risk factors can be used in models to stratify risk of EOC, and aid in decisions regarding risk-reduction strategies. Germline pathogenic variants in EOC susceptibility genes including those involved in homologous recombination and mismatch repair pathways are present in approximately 22% to 25% of EOC. These genes are associated with an estimated lifetime risk of EOC of 13% to 60% for BRCA1 variants and 10% to 25% for BRCA2 variants, with lower risks associated with remaining genes. Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) thought to explain an additional 6.4% of the familial risk of ovarian cancer, with 34 susceptibility loci identified to date. However, an unknown proportion of the genetic component of EOC risk remains unexplained. This review comprises an overview of individual genes and SNPs suspected to contribute to risk of EOC, and discusses use of a polygenic risk score to predict individual cancer risk more accurately. 相似文献
64.
65.
66.
67.
Implications for Practice
Breast cancer is far more curable than in the past but requires multimodality treatment. Great care must be taken to use the least leukemogenic treatment programs that do not sacrifice efficacy. Elimination of radiation and anthracycline/alkylating agent regimens will be helpful where possible, particularly in younger patients and possibly those with homologous repair deficiency (HRD). Use of colony-stimulating factors should be limited to those who truly require them for safe chemotherapy administration. Further study of a possible leukemogenic association with HRD and the various forms of colony-stimulating factors is badly needed.68.
69.
70.